ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Impact of monocyte to high-density lipoprotein ratio on prevalent hyperuricemia: findings from a rural Chinese population

Meng-Qi, Chen; Wen-Rui, Shi; Chu-Ning, Shi; Ya-Ping, Zhou; Ying-Xian, Sun
Lipids in Health and Disease2020-12DOI: 10.1186/s12944-020-01226-6
3被引11阅读
引用收藏
分享

摘要

<jats:title>Abstract</jats:title><jats:sec> <jats:title>Background</jats:title> <jats:p>Monocyte to high-density lipoprotein cholesterol ratio (MHR) is a novel inflammatory marker that has been used to predict various inflammation-related diseases. This study aims to explore the association between MHR and prevalent hyperuricemia in a rural Chinese population.</jats:p> </jats:sec><jats:sec> <jats:title>Methods</jats:title> <jats:p>8163 eligible participants (mean age: 54.13 years, males: 45.71%) from northeast China were enrolled in this cross-sectional study between 2012 to 2013. MHR was determined as blood monocyte count ratio to high-density lipoprotein cholesterol concentration.</jats:p> </jats:sec><jats:sec> <jats:title>Results</jats:title> <jats:p>The prevalence of hyperuricemia was 12.86%. After adjusting for potential confounding factors, per SD increase of MHR caused a 25.2% additional risk for hyperuricemia, and the top quartile of MHR had an 82.9% increased risk for hyperuricemia compared with the bottom quartile. Additionally, smooth curve fitting and subgroup analyses showed a linear and robust association between MHR and prevalent hyperuricemia respectively. Finally, after introducing MHR into the established model of risk factors, the AUC displayed a significant improvement (0.718 vs 0.724, <jats:italic>p</jats:italic> = 0.008). Furthermore, Category-free net reclassification improvement (0.160, 95% CI: 0.096–0.224, <jats:italic>P</jats:italic> &lt; 0.001) and integrated discrimination improvement (0.003, 95% CI: 0.002–0.005, <jats:italic>P</jats:italic> &lt; 0.001) also demonstrated significant improvements.</jats:p> </jats:sec><jats:sec> <jats:title>Conclusions</jats:title> <jats:p>The present study suggests that MHR was positively and independently correlated with prevalent hyperuricemia among rural Chinese adults. Our results also implicate an important value for MHR in optimizing the risk stratification of hyperuricemia.</jats:p> </jats:sec>

相关
加载中…
  • The monocyte to high-density lipoprotein cholesterol ratio and outcomes in type 2 diabetes mellitus patients with non-ST-segment elevation acute coronary syndrome
    Li, Chen; Fan, Hualin; Liu, Yuanhui; Zeng, Lihuan; Chen, Pengyuan; Duan, Chongyang; Liang, Huasheng; He, Pengcheng*Annals of Translational Medicine, 2021, 9(21): 1627.被引 9
  • Associaton of Retinol Binding Protein 4 (RBP4) Levels With Hyperuricemia: A Cross-Sectional Study in a Chinese Population
    Hong, Guo-bao; Shao, Xiao-fei; Li, Jia-min; Zhou, Qin; Ke, Xiao-Su; Gao, Pei-Chun; Li, Xiao-Lin; Ning, Jing; Chen, Hai-Shan; Xiao, Hua; Xiong, Chong-Xiang*; Zou, Hequn*Frontiers in Endocrinology, 2022, 13: 879755.
  • The Effect of Body Weight and Alcohol Consumption on Hyperuricemia and Their Population Attributable Fractions: A National Health Survey in China
    He, Huijing; Pan, Li; Ren, Xiaolan; Wang, Dingming; Du, Jianwei; Cui, Ze; Zhao, Jingbo; Wang, Hailing; Wang, Xianghua; Liu, Feng; Pa, Lize; Peng, Xia; Wang, Ye; Yu, Chengdong; Shan, Guangliang*Obesity Facts, 2022, 15(2): 216-227.被引 17
查看全部 →

发表信息

论文状态
公开发表
期刊
Lipids in Health and Disease
发表日期
2020-12
卷期
第 19 卷, 第 1 期
页码
48
DOI
10.1186/s12944-020-01226-6
语言
ENGLISH
期刊收录
NSL.SCIE
期刊等级
3区
资助标注
Thirteenth Five-Year" program[2017YFC1307600]

作者

  • M

    Meng-Qi, Chen (第一作者)

  • W

    Wen-Rui, Shi

查看全部 5 位作者收起作者
  • C

    Chu-Ning, Shi

  • Y

    Ya-Ping, Zhou

  • Y

    Ying-Xian, Sun

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417